Fitzgerald, Gillian E. http://orcid.org/0000-0001-5930-3928
O’Dwyer, Tom http://orcid.org/0000-0002-8072-4783
Mockler, David http://orcid.org/0000-0001-6171-8751
O’Shea, Finbar D. http://orcid.org/0000-0001-9465-650X
Wilson, Fiona http://orcid.org/0000-0002-0292-1087
Article History
Received: 14 April 2020
Accepted: 2 June 2020
First Online: 16 June 2020
Compliance with ethical standards
:
: Dr. Fitzgerald reports non-financial support from Pfizer Pharmaceuticals, non-financial support from AbbVie Pharmaceuticals, outside the submitted work. Mr. Mockler has nothing to disclose. Dr. O’ Dwyer has nothing to disclose. Dr. O’Shea reports personal fees from Lilly, personal fees from Abbvie, personal fees from Novartis, personal fees from Boheringer, personal fees from Gilead, personal fees from UCB, personal fees from Roche, personal fees from Sanofi, outside the submitted work. Dr. Wilson has nothing to disclose.
: No part of the review is copied or published elsewhere.